Asensus Surgical Analyst Ratings
Asensus Surgical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/22/2023 | 257.4% | Cantor Fitzgerald | → $1 | Reiterates | Overweight → Overweight |
| 08/11/2023 | 614.8% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 05/12/2023 | 614.8% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 03/06/2023 | 614.8% | HC Wainwright & Co. | $3 → $2 | Maintains | Buy |
| 02/22/2023 | 972.19% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 01/10/2023 | 972.19% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 09/08/2022 | 436.1% | Cantor Fitzgerald | → $1.5 | Initiates Coverage On | → Overweight |
| 08/10/2022 | 972.19% | HC Wainwright & Co. | $4 → $3 | Maintains | Buy |
| 05/26/2021 | 1329.59% | HC Wainwright & Co. | → $4 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月22日 | 257.4% | 康託·菲茨傑拉德 | →$1 | 重申 | 超重→超重 |
| 2023年08月11日 | 614.8% | HC Wainwright公司 | →$2 | 重申 | 購買→購買 |
| 2023年05月12日 | 614.8% | HC Wainwright公司 | →$2 | 重申 | 購買→購買 |
| 03/06/2023 | 614.8% | HC Wainwright公司 | $3→$2 | 維護 | 買 |
| 02/22/2023 | 972.19% | HC Wainwright公司 | →$3 | 重申 | →購買 |
| 2023年1月10日 | 972.19% | HC Wainwright公司 | →$3 | 重申 | →購買 |
| 09/08/2022 | 436.1% | 康託·菲茨傑拉德 | →$1.5 | 開始承保 | →超重 |
| 2022年08月10日 | 972.19% | HC Wainwright公司 | $4→$3 | 維護 | 買 |
| 2021/05/26 | 1329.59% | HC Wainwright公司 | →$4 | 開始承保 | →購買 |
What is the target price for Asensus Surgical (ASXC)?
Ascount Surgical(ASXC)的目標價格是多少？
The latest price target for Asensus Surgical (AMEX: ASXC) was reported by Cantor Fitzgerald on August 22, 2023. The analyst firm set a price target for $1.00 expecting ASXC to rise to within 12 months (a possible 257.40% upside). 7 analyst firms have reported ratings in the last year.
2023年8月22日，Cantor Fitzgerald報道了Ascount Surgical(美國證券交易所代碼：ASXC)的最新目標價。這家分析公司將目標價定為1美元，預計ASXC將在12個月內上漲至(可能上漲257.40%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Asensus Surgical (ASXC)?
Ascount Surgical(ASXC)的最新分析師評級是多少？
The latest analyst rating for Asensus Surgical (AMEX: ASXC) was provided by Cantor Fitzgerald, and Asensus Surgical reiterated their overweight rating.
美國證券交易所股票代碼：ASXC的最新分析師評級是由坎託·菲茨傑拉德提供的，Ascount Surgical重申了他們的增持評級。
When is the next analyst rating going to be posted or updated for Asensus Surgical (ASXC)?
Ascount Surgical(ASXC)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Asensus Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Asensus Surgical was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Ascount Surgical的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Ascount Surgical的上一次評級是在2023年8月22日提交的，所以你應該預計下一次評級將在2024年8月22日左右提供。
Is the Analyst Rating Asensus Surgical (ASXC) correct?
分析師評級評估外科(ASXC)正確嗎？
While ratings are subjective and will change, the latest Asensus Surgical (ASXC) rating was a reiterated with a price target of $0.00 to $1.00. The current price Asensus Surgical (ASXC) is trading at is $0.28, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Ascount Surgical(ASXC)評級被重申，目標價在0.00美元至1.00美元之間。Ascount Surgical(ASXC)目前的交易價格為0.28美元，在分析師的預測範圍內。